3SOF

ACTC is monster. No doubt.

I keep having to redraw my trend line on my 5 minute chart upward, now I know why they call it parabolic.  Looking at the weekly chart going back to $8 I dont know where there would be any meaningful resistance, maybe the gap at $3.49?  

Anyway, sold half just now at 1.86 for the other half free shares like boatguy, will just kick back now and see what happens, first time for me to get 100% profit in about an hour  

More news:

http://biz.yahoo.com/bw/060823/20060823005716.html?.v=1
---------------------------------------------------------------------------------------------

Advanced Cell to Host Investor Conference Call to Discuss Breakthrough Technique to Generate Embryonic Stem Cells without Harming Embryo
Wednesday August 23, 4:43 pm ET 
Proprietary Method May Remove Ethical and Political Obstacles to Stem Cell Research and Federal Funding


ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 23, 2006--Advanced Cell Technology, Inc. (OTCBB:ACTC - News), developers of groundbreaking human embryonic stem cell technologies to create next-generation medical therapies, will hold an investor conference call on Friday, August 25, 2006, at 12 noon Eastern, to discuss its novel technique to generate human embryonic stem cell lines from embryos while fully preserving the embryo's potential for life and development.
ADVERTISEMENT



The proprietary technique, which was recently published in the scientific journal "Nature," aims to resolve many of the ethical issues currently stunting embryonic stem cell research and may finally open the door to needed funding from the federal government.

During the conference call, William M. Caldwell IV, Chief Executive Officer of Advanced Cell Technology (ACT), and Dr. Michael D. West, Ph.D., President and Chief Scientific Officer of ACT, will discuss the company's scientific advances and business initiatives, and will address investor questions.

Among the primary ethical objections of those who oppose the generation of human embryonic stem cells is that all techniques, until now, have resulted in the destruction of the embryo. The company's newly published proprietary technique may overcome this hurdle, offering the potential to speed the progress of stem cell science from laboratory to bedside.

"We hope that this new technique will allow us to make stem cell lines widely available for researchers around the country," said Mr. Caldwell. "Our goal is to help accelerate basic research and enable the translation of that research into real cures and treatments for many of the world's most devastating diseases."

In the paper in "Nature," ACT scientists described their technique to generate human embryonic stem cells (hES cells) using a method for deriving stem cells from human blastomeres with a single-cell biopsy technique called Preimplantation Genetic Diagnosis (PGD). PGD is a widely used practice used at in vitro fertilization (IVF) clinics to assess the genetic health of preimplantation embryos. To date, more than 1,500 healthy children have been born following the procedure, and live with their families today.

Current embryonic stem cell technology is the source of a heated national controversy because it derives hES cells from the inner cell mass of later-stage embryos known as blastocysts, destroying their potential for further development. "What has made ACT's novel approach so groundbreaking is its ability to generate stem cell lines of equal scientific value from a single cell obtained from an 8-cell-stage embryo, while maintaining the embryo's potential to develop normally," said Mr. Caldwell.

Callers within the United States can access the conference call by calling (800) 230-1074, when prompted tell the operator you would like to connect to the 'Advanced Cell Technology conference call.' International callers can dial (612) 332-0228. An online audio web simulcast of the call will also be accessible at http://www.trilogy-capital.com/tcp/advanced_cell/.

About Advanced Cell Technology, Inc.

Advanced Cell Technology Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information, please visit: www.advancedcell.com. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/advanced_cell. To view recent stock quotes and news, visit http://www.trilogy-capital.com/tcp/advanced_cell/quote.html.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.



Contact:
Financial Dynamics
Robert Stanislaro, 212-850-5657 (Media)
or
The Investor Relations Group
James Carbonara, 212-825-3210 (Investors)
or
Financial Communications
Trilogy Capital Partners
Paul Karon, 800-592-6067
[email protected]

Well this one may run further...at least until the Conference Call.  ACTC made the CBS Evening News tonight.

http://www.cbsnews.com/stories/2006/08/23/tech/main1929295.shtml

So sad I sold too early.  But will watch early tomorrow for any pullback.

ACTC may runaway even tomorrow. Only 17 million float and big momo action. As much as I like it I wont be buying at current levels. I already have few hundred free shares, so I am not putting my neck here. If you can watch the tape then you may make in a day what many would do in a year. But unlike today I can't watch the market. So not my cup of tea.

In addition it reminds me of ISON when it ran all the way from around 70cents to 6.5$ in few days. Likewise I see ACTC train not stopping anytime soon. Be careful.

Good job guys and gals !! 
Applaud to everyone on this thread...... 

ACTC traded more shares in the pre market than it did the entire day two days ago.  This is going to be an interesting day!

Update:  though my remaining shares were "free", I sold them at an average of 1.70.  should have sold the gap up in retrospect, but I am not complaining, this was a great ride.  I will watch from the sidelines, but volume started to dry up, and the candle today will probably be dark cloud cover.  maybe a pullback to the 50sma might be buyable.

Simply amazing...
France tv news (TF1) - 20h30 -  just spoke now about this new progress !!!

D.

Still holding my free ACTC. Will see tomorrow action.

hi,
just bounced off a dollar. i hope no one here bought at 2
maxi

Congrats all who had success with this one. News this AM regaring repricing of warrants from existing $2.53 and $1.27  down to $0.95 caused the price fall. Might make $0.95 a good entry as the warrants are priced right there? That said this type of fiancing and the super volatility makes this a real crap shoot now.
The conf call starts at 12:00 today so I assume very high volatility leading up to that.

I am watching as only caught this late:

ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 25, 2006--Advanced Cell Technology, Inc.
(OTCBB: ACTC) today announced two separate financing transactions.

Advanced Cell received notices on August 23, 2006 from substantially all of the
holders of the Company's currently outstanding amortizing convertible debentures
and common stock purchase warrants issued September 15, 2005, exercising their
existing additional investment option to purchase additional debentures
and warrants. Upon closing, the additional investment option will
generate approximately $8.5 million in new capital. The Company expects
the closing to occur on or about September 7, 2007.

The terms and conditions of the additional debentures and warrants will be
substantially the same as the existing debentures and warrants, with the
exception that the conversion price for the debentures and the exercise price
for the warrants will be established based upon average closing prices for the
five days preceding the notice of exercise in accordance with the terms of the
existing investment option.

In addition, the Company has agreed to reduce the exercise price of its
currently outstanding $2.53 warrants and $1.27 warrants to $0.95 per share,
provided that a minimum of 85% of the holders of the $2.53 warrants exercise the
warrants as repriced. In connection with the repricing, the Company will issue a
replacement warrant to each warrant holder exercising the repriced warrant on
the same terms and conditions as the existing warrant at a price of $1.60. The
Company anticipates receiving funds from the exercise of the repriced
warrants in the amount of approximately $5,000,000. The shares underlying
the $1.27 warrants are not subject to a current registration statement.

In light of the exercise of the additional investment option and the warrant
transaction, the Company has terminated the private placement financing
announced August 22, 2006, as the need for that capital has been satisfied.

Additional details regarding both of the financings will be included in a
Current Report on Form 8-K to be filed by the Company with the Securities and
Exchange Commission. The additional investment option will be a private
placement made only to accredited buyers in accordance with Section 4(2) of the
Securities Act. The Securities will not be registered under the Securities Act
and may not be offered or sold without registration unless an exemption from
such registration is available. This notice is issued pursuant to Rule 135c of
the Securities Act, and does not constitute an offer to sell the Securities, nor
a solicitation for an offer to purchase the Securities.

Yup, i was ready in advance with a buy order in at .96 and of course it skipped me and gave it to a few others...grrrrrr...even when i pick the perfect price to get in at...they won't give me the shares! I only manage to get the shares when they don't want them! ...whoa is me...lol


glta

julia

With the huge volume in this stock it is hard to get an order filled.  I had to chase the first time 2 days ago from .78 to .9 and it was worth it then, but I was trying to get in around 1.00 this morning and gave up as I found myself chasing it to 1.08.  

I gave up in part because I didnt want to chase, and in part because I saw the news about the dilution.  Until then I just thought that the drop was a natural drop to midway on the big white candle, but dilution is not good.

Of course all that being said it is at 1.13 right now, may run into the conference call.

Pullback looks like it may go down to that 50sma,I would be interested there..

Looking good for the next ride up..